‌

Synfini

Synfini, Inc. is a Menlo Park–based biotech startup spun out from SRI International, specializing in AI-powered drug discovery and chemistry automation. Led by CEO Doug Donzelli, it serves pharmaceutical and biotech clients with cutting-edge molecular design technology.

Overview Structured Data Issues Contributors

Is a

Company attributes

Industry

Artificial Intelligence (AI)

Drug development

Location

Menlo Park, California

B2X

CEO

Founder

Number of Employees (Ranges)

1 – 10

Email Address

info@synfini.com

Investors

JSL Health Capital

Founded Date

2023

Total Funding Amount (USD)

8,900,000

Latest Funding Round Date

July 7, 2025

Latest Funding Type

Other attributes

Latest Funding Round Amount (USD)

8,900,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Synfini

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.